Tempus
PublicTempus is now publicly traded
The data on this page reflects Tempus's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jun 14, 2024
Last Round
Early Funding
Oct 20, 2022
Total Funding Raised
$1.51B
Company Overview
Tempus is a healthcare technology company that offers a platform designed to integrate and optimize healthcare data while utilizing AI to enhance the accuracy and personalization of laboratory diagnostics.
Sector
Healthcare/Wellness
AI Layer
Application
Keywords
Tempus Comparables
Compare Tempus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genomics | 59% | |
| PreOncology | 46% | |
| Aegis Health Services | 40% |
Tempus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jun 14, 2024 | ||||
| Early Funding | Oct 20, 2022 | ||||
| Series G Extension | Dec 10, 2020 | ||||
| Series G | Mar 13, 2020 | ||||
| Series F | May 30, 2019 | ||||
Series E | Aug 29, 2018 |
Tempus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lightbank | Series A |
| New Enterprise Associates (NEA) | Series D, Series F, IPO, Series G, Series E, Series C |
| Scottish Mortgage Investment Trust | Series G, Series G Extension |
| Revolution Group | Series C, Series F, Series E |
| Revolution Ventures | Series D, Series C |
| BofA Securities | IPO |
| SoftBank Group | IPO |
Tempus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access